![Florian Jehle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Florian Jehle
Chief Executive Officer at
Vifor Fresenius Medical Care Renal Pharma Ltd.
Profile
Florian Jehle currently works at Vifor Fresenius Medical Care Renal Pharma Ltd., as Chief Executive Officer from 2022 and Fresenius Medical Care Ventures GmbH, as Managing Director from 2016.
Florian Jehle active positions
| Companies | Position | Start |
|---|---|---|
Fresenius Medical Care Ventures GmbH
 Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Director/Board Member | 09/02/2016 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Chief Executive Officer | 31/03/2022 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
8
1st degree connections
2
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease | Health Technology |
Fresenius Medical Care Ventures GmbH
Fresenius Medical Care Ventures GmbH Investment ManagersFinance Fresenius Medical Care Ventures provides financing for early stage capital requirements. It invests in companies that develop technologies, products, and therapies for patients and the healthcare system. It targets companies located in Europe and North America that operate in the fields of medical devices, patient monitoring, eHealth solutions, regenerative medicine, and pharmaceuticals. | Finance |
- Stock Market
- Insiders
- Florian Jehle
Choose MarketScreener 
